cost-effectiveness gargling prevention upper respiratory tract infections abstract background japan gargling generally accepted preventing upper respiratory tract infection urti effectiveness gargling preventing urti shown randomized controlled trial compared incidences urti gargling control groups perspective third-party payer gargling dominant due fact costs gargling borne participant cost-effectiveness gargling societal perspective considered study economic evaluation alongside randomized controlled trial performed evaluate cost-effectiveness gargling preventing urti societal perspective methods participants gargling trial num water-gargling num control subjects involved economic analysis sixty-day cumulative follow-up costs effectiveness measured quality-adjusted life days qald compared groups intention-to-treat basis incremental cost-effectiveness ratio icer converted dollars quality-adjusted life years qaly num confidence interval num ci probability gargling cost-effective estimated bootstrapping results num days qald increased num costs num higher gargling group control group icer gargling group num qaly num ci num num resembles acceptable forms medical intervention including urti preventive measures influenza vaccination broad confidence interval uncertainty surrounding results addition one-way sensitivity analysis careful evaluation required cost gargling utility moderate urti major limitation study trial conducted winter time urti prevalent care applying results season urti prevalent icer increase due decreases incidence conclusion study suggests gargling cost-effective preventive strategy urti acceptable perspectives third-party payer society 
